ESPR icon

Esperion Therapeutics

139 hedge funds and large institutions have $299M invested in Esperion Therapeutics in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less first-time investments, than exits

New positions opened: | Existing positions closed:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

12.7% less ownership

Funds ownership: 100.53%87.84% (-13%)

19% less call options, than puts

Call options by funds: $9.22M | Put options by funds: $11.4M

50% less capital invested

Capital invested by funds: $598M → $299M (-$299M)

Holders
139
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.22M
Puts
$11.4M
Net Calls
Net Calls Change

Top Buyers

1 +$3.06M
2 +$2.31M
3 +$2.23M
4
CS
Credit Suisse
Switzerland
+$1.92M
5
Millennium Management
Millennium Management
New York
+$1.81M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$54.5M
2
$39.5M
3
$34M
4
$24.2M
5
$22.2M
6
$20.6M
7
$7.5M
8
$6.96M
9
$6.27M
10
$5.63M
11
$5.44M
12
$4.12M
13
$3.55M
14
$3.54M
15
$3.15M
16
$3.12M
17
$3.09M
18
$3.07M
19
$2.61M
20
$2.23M
21
$2.04M
22
$1.77M
23
$1.59M
24
$1.52M
25
$1.46M